Apixaban: A Clinical Pharmacokinetic and Pharmacodynamic …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769096/
WebMay 14, 2019 · Apixaban is an oral, direct factor Xa inhibitor that inhibits both free and clot-bound factor Xa, and has been approved for clinical use in several thromboembolic disorders, including reduction of stroke risk in non-valvular atrial fibrillation, thromboprophylaxis following hip or knee replacement surgery, the treatment of deep vein thrombosis o...
DA: 87 PA: 45 MOZ Rank: 2 Up or Down: Up